| Ytd | -6.65% | |
| 1y | -12.07% |
| Open | 61.16 | Prev Close | 60.83 | Low | 59.49 | High | 61.25 | Mkt Cap | 5.62B |
| Vol | 512.71K | Avg Vol | 915.81K | EPS | 2.35 | P/E | 25.51 | Forward P/E | 13.10 |
| Beta | 0.78 | Short Ratio | 6.11 | Inst. Own | 106.61% | Dividend | 1.44 | Div Yield | 2.37 |
| Ex Div Date | 08-11 | Earning | 11-17 | 50-d Avg | 60.72 | 200-d Avg | 59.38 | 1yr Est | 79.00 |
SAN FRANCISCO, Oct. 12, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immer
Dolby Laboratories (NYSE: DLB - Get Free Report) and Palo Alto Networks (NASDAQ: PANW - Get Free Rep
Dolby Laboratories (NYSE: DLB - Get Free Report) and Aware (NASDAQ: AWRE - Get Free Report) are both
Dolby Laboratories is rated Buy due to its high margins, robust buyback program, and undervalued sha
October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3 October
DLB expands across Meta's ecosystem as Dolby Atmos and Vision reach AI glasses, Instagram and VR, br
Meta expands Dolby Atmos & Vision across AI glasses, Instagram, and VR. Get the tech details and
Dolby Laboratories (NYSE: DLB - Get Free Report) and Zscaler (NASDAQ: ZS - Get Free Report) are both
Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's EcosystemPR NewswireSAN FRANCISCO a
/PRNewswire/ -- Today, Dolby Laboratories (NYSE: DLB) and Meta (NASDAQ: META) announced the expansio
SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB) ("Dolby"), a lead
New Sports Intelligence helps providers better understand and deepen fan engagement, as Dolby Vision
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are l
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Artificial Life (OTCMKTS:ALIF - Get Free Report) and Dolby Laboratories (NYSE: DLB - Get Free Report
Kevin Yeaman to Retire from Dolby Marc Whitten Named President, Chief Executive Officer and Directo
Cinemo, a global leader and one-stop-shop provider for fully integrated, innovative multi-device in-
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies
Assenagon Asset Management S.A. increased its stake in shares of Dolby Laboratories (NYSE: DLB) by 8
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Amazon surges 15% on an AWS blowout while Apple sheds nearly $475 billion in value. Yields sit at cy
U.S. stocks mixed, Nasdaq up 50 pts. AXT Inc (NASDAQ: AXTI) rose 25.3% on strong Q2 results. Other g
Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.
Dolby Laboratories (NYSE:DLB) lowers FY2026 Adj EPS guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.3
Dolby Laboratories (NYSE:DLB) is looking for Q4 Adj EPS of $1.13-$1.28 vs $1.20 analyst estimate. se
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.69 per share which beat the analyst
Find bargains in oversold IT stocks with RSI values below 30: Fabrinet (NYSE: FN), Dolby Laboratorie
U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on
Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.56-$0.71 vs $0.98 analyst estimate. se
Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.
Dolby Laboratories (NYSE:DLB) affirms FY2026 Adj EPS guidance from $4.30-$4.45 to $4.30-$4.45 vs $4.
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.37 per share which beat the analyst
Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperfo
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain
Dolby Laboratories (NYSE:DLB) raises FY2026 GAAP EPS guidance from $2.61-$2.76 to $2.71-$2.86 vs $2.
Dolby Laboratories (NYSE:DLB) raises FY2026 Adj EPS guidance from $4.19-$4.34 to $4.30-$4.45 vs $4.2
Dolby Laboratories (NYSE:DLB) is looking for Q2 Adj EPS of $1.29-$1.44 vs $1.37 analyst estimate. se
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.06 per share which beat the analyst
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain
https://aws.amazon.com/blogs/media/from-flat-to-full-immersion-the-aws-path-to-dolby-vision-and-dolb
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers t
Dolby Laboratories (NYSE:DLB) is looking for FY2026 Adj EPS of $4.19-$4.34 vs $3.96 analyst estimate